The Global Biologic Drugs Market was valued at US$ 331.4 billion in 2023 and is projected to reach US$ 578.1 billion by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period (2023-2030).
Report Overview
This report provides a deep insight into the global Biologic Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biologic Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biologic Drugs market in any manner.
Global Biologic Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Roche
- Abbott Laboratories
- Johnson & Johnson
- Merck & Co.
- Pfizer
- Amgen
- Sanofi
- Novartis
- Eli Lilly
- Amgen
- Including or Excluding key companies relevant to your analysis.
Market Segmentation (by Type)
- Humira
- Remicade
- Rituxan
- Enbrel
- Lantus
- Avastin
- Herceptin
- Others
Market Segmentation (by Application)
- Diabetes
- Inflammation
- Auto-Immune Diseases
- Blood Diseases
- Cardiovascular Diseases
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Biologic Drugs Market
- Overview of the regional outlook of the Biologic Drugs Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biologic Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Biologic Drugs
1.2 Key Market Segments
1.2.1 Biologic Drugs Segment by Type
1.2.2 Biologic Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Biologic Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Biologic Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biologic Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Biologic Drugs Market Competitive Landscape
3.1 Global Biologic Drugs Sales by Manufacturers (2019-2024)
3.2 Global Biologic Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Biologic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biologic Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biologic Drugs Sales Sites, Area Served, Product Type
3.6 Biologic Drugs Market Competitive Situation and Trends
3.6.1 Biologic Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biologic Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Biologic Drugs Industry Chain Analysis
4.1 Biologic Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Biologic Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Biologic Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biologic Drugs Sales Market Share by Type (2019-2024)
6.3 Global Biologic Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Biologic Drugs Price by Type (2019-2024)
7 Biologic Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biologic Drugs Market Sales by Application (2019-2024)
7.3 Global Biologic Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Biologic Drugs Sales Growth Rate by Application (2019-2024)
8 Biologic Drugs Market Segmentation by Region
8.1 Global Biologic Drugs Sales by Region
8.1.1 Global Biologic Drugs Sales by Region
8.1.2 Global Biologic Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Biologic Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biologic Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biologic Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biologic Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biologic Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Roche
9.1.1 Roche Biologic Drugs Basic Information
9.1.2 Roche Biologic Drugs Product Overview
9.1.3 Roche Biologic Drugs Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Biologic Drugs SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Abbott Laboratories
9.2.1 Abbott Laboratories Biologic Drugs Basic Information
9.2.2 Abbott Laboratories Biologic Drugs Product Overview
9.2.3 Abbott Laboratories Biologic Drugs Product Market Performance
9.2.4 Abbott Laboratories Business Overview
9.2.5 Abbott Laboratories Biologic Drugs SWOT Analysis
9.2.6 Abbott Laboratories Recent Developments
9.3 Johnson and Johnson
9.3.1 Johnson and Johnson Biologic Drugs Basic Information
9.3.2 Johnson and Johnson Biologic Drugs Product Overview
9.3.3 Johnson and Johnson Biologic Drugs Product Market Performance
9.3.4 Johnson and Johnson Biologic Drugs SWOT Analysis
9.3.5 Johnson and Johnson Business Overview
9.3.6 Johnson and Johnson Recent Developments
9.4 Merck and Co.
9.4.1 Merck and Co. Biologic Drugs Basic Information
9.4.2 Merck and Co. Biologic Drugs Product Overview
9.4.3 Merck and Co. Biologic Drugs Product Market Performance
9.4.4 Merck and Co. Business Overview
9.4.5 Merck and Co. Recent Developments
9.5 Pfizer
9.5.1 Pfizer Biologic Drugs Basic Information
9.5.2 Pfizer Biologic Drugs Product Overview
9.5.3 Pfizer Biologic Drugs Product Market Performance
9.5.4 Pfizer Business Overview
9.5.5 Pfizer Recent Developments
9.6 Amgen
9.6.1 Amgen Biologic Drugs Basic Information
9.6.2 Amgen Biologic Drugs Product Overview
9.6.3 Amgen Biologic Drugs Product Market Performance
9.6.4 Amgen Business Overview
9.6.5 Amgen Recent Developments
9.7 Sanofi
9.7.1 Sanofi Biologic Drugs Basic Information
9.7.2 Sanofi Biologic Drugs Product Overview
9.7.3 Sanofi Biologic Drugs Product Market Performance
9.7.4 Sanofi Business Overview
9.7.5 Sanofi Recent Developments
9.8 Novartis
9.8.1 Novartis Biologic Drugs Basic Information
9.8.2 Novartis Biologic Drugs Product Overview
9.8.3 Novartis Biologic Drugs Product Market Performance
9.8.4 Novartis Business Overview
9.8.5 Novartis Recent Developments
9.9 Eli Lilly
9.9.1 Eli Lilly Biologic Drugs Basic Information
9.9.2 Eli Lilly Biologic Drugs Product Overview
9.9.3 Eli Lilly Biologic Drugs Product Market Performance
9.9.4 Eli Lilly Business Overview
9.9.5 Eli Lilly Recent Developments
9.10 Amgen
9.10.1 Amgen Biologic Drugs Basic Information
9.10.2 Amgen Biologic Drugs Product Overview
9.10.3 Amgen Biologic Drugs Product Market Performance
9.10.4 Amgen Business Overview
9.10.5 Amgen Recent Developments
10 Biologic Drugs Market Forecast by Region
10.1 Global Biologic Drugs Market Size Forecast
10.2 Global Biologic Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biologic Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Biologic Drugs Market Size Forecast by Region
10.2.4 South America Biologic Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biologic Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Biologic Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biologic Drugs by Type (2025-2030)
11.1.2 Global Biologic Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biologic Drugs by Type (2025-2030)
11.2 Global Biologic Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Biologic Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Biologic Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biologic Drugs Market Size Comparison by Region (M USD)
Table 5. Global Biologic Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Biologic Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biologic Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biologic Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Drugs as of 2022)
Table 10. Global Market Biologic Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biologic Drugs Sales Sites and Area Served
Table 12. Manufacturers Biologic Drugs Product Type
Table 13. Global Biologic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biologic Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biologic Drugs Market Challenges
Table 22. Global Biologic Drugs Sales by Type (Kilotons)
Table 23. Global Biologic Drugs Market Size by Type (M USD)
Table 24. Global Biologic Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Biologic Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Biologic Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Biologic Drugs Market Size Share by Type (2019-2024)
Table 28. Global Biologic Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Biologic Drugs Sales (Kilotons) by Application
Table 30. Global Biologic Drugs Market Size by Application
Table 31. Global Biologic Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Biologic Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Biologic Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Biologic Drugs Market Share by Application (2019-2024)
Table 35. Global Biologic Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Biologic Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Biologic Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Biologic Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Biologic Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Biologic Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Biologic Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Biologic Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Roche Biologic Drugs Basic Information
Table 44. Roche Biologic Drugs Product Overview
Table 45. Roche Biologic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Roche Business Overview
Table 47. Roche Biologic Drugs SWOT Analysis
Table 48. Roche Recent Developments
Table 49. Abbott Laboratories Biologic Drugs Basic Information
Table 50. Abbott Laboratories Biologic Drugs Product Overview
Table 51. Abbott Laboratories Biologic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Abbott Laboratories Business Overview
Table 53. Abbott Laboratories Biologic Drugs SWOT Analysis
Table 54. Abbott Laboratories Recent Developments
Table 55. Johnson and Johnson Biologic Drugs Basic Information
Table 56. Johnson and Johnson Biologic Drugs Product Overview
Table 57. Johnson and Johnson Biologic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Johnson and Johnson Biologic Drugs SWOT Analysis
Table 59. Johnson and Johnson Business Overview
Table 60. Johnson and Johnson Recent Developments
Table 61. Merck and Co. Biologic Drugs Basic Information
Table 62. Merck and Co. Biologic Drugs Product Overview
Table 63. Merck and Co. Biologic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Merck and Co. Business Overview
Table 65. Merck and Co. Recent Developments
Table 66. Pfizer Biologic Drugs Basic Information
Table 67. Pfizer Biologic Drugs Product Overview
Table 68. Pfizer Biologic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Pfizer Business Overview
Table 70. Pfizer Recent Developments
Table 71. Amgen Biologic Drugs Basic Information
Table 72. Amgen Biologic Drugs Product Overview
Table 73. Amgen Biologic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Amgen Business Overview
Table 75. Amgen Recent Developments
Table 76. Sanofi Biologic Drugs Basic Information
Table 77. Sanofi Biologic Drugs Product Overview
Table 78. Sanofi Biologic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Sanofi Business Overview
Table 80. Sanofi Recent Developments
Table 81. Novartis Biologic Drugs Basic Information
Table 82. Novartis Biologic Drugs Product Overview
Table 83. Novartis Biologic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Novartis Business Overview
Table 85. Novartis Recent Developments
Table 86. Eli Lilly Biologic Drugs Basic Information
Table 87. Eli Lilly Biologic Drugs Product Overview
Table 88. Eli Lilly Biologic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Eli Lilly Business Overview
Table 90. Eli Lilly Recent Developments
Table 91. Amgen Biologic Drugs Basic Information
Table 92. Amgen Biologic Drugs Product Overview
Table 93. Amgen Biologic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Amgen Business Overview
Table 95. Amgen Recent Developments
Table 96. Global Biologic Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Biologic Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Biologic Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Biologic Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Biologic Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Biologic Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Biologic Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Biologic Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Biologic Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Biologic Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Biologic Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Biologic Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Biologic Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Biologic Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Biologic Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Biologic Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Biologic Drugs Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Biologic Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biologic Drugs Market Size (M USD), 2019-2030
Figure 5. Global Biologic Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Biologic Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biologic Drugs Market Size by Country (M USD)
Figure 11. Biologic Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Biologic Drugs Revenue Share by Manufacturers in 2023
Figure 13. Biologic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biologic Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biologic Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biologic Drugs Market Share by Type
Figure 18. Sales Market Share of Biologic Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Biologic Drugs by Type in 2023
Figure 20. Market Size Share of Biologic Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Biologic Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biologic Drugs Market Share by Application
Figure 24. Global Biologic Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Biologic Drugs Sales Market Share by Application in 2023
Figure 26. Global Biologic Drugs Market Share by Application (2019-2024)
Figure 27. Global Biologic Drugs Market Share by Application in 2023
Figure 28. Global Biologic Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biologic Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Biologic Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Biologic Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Biologic Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Biologic Drugs Sales Market Share by Country in 2023
Figure 37. Germany Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Biologic Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Biologic Drugs Sales Market Share by Region in 2023
Figure 44. China Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Biologic Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Biologic Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Biologic Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Biologic Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Biologic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Biologic Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Biologic Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biologic Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biologic Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Biologic Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Biologic Drugs Market Share Forecast by Application (2025-2030)
